A clinical study of ADI-100 from treatment of Stiff Person Syndrome
Latest Information Update: 22 Aug 2023
At a glance
- Drugs ADI 100 (Primary)
- Indications Stiff-person syndrome
- Focus Adverse reactions
Most Recent Events
- 18 Aug 2023 According to an ADiTxT Therapeutics media release, the company plans to start this trial Q4 2023. - Mayo Clinic is currently working to enroll 15 to 20 patients and initial screenings have begun.
- 10 May 2023 New trial record
- 05 May 2023 According to an ADiTxT Therapeutics media release, the company plans to start this study at Mayo Clinic and plans to enroll approximately 10-15 patients. The clinical trial is expected to begin in 2023.